CD44 enhances invasion of basal-like breast cancer cells by upregulating serine protease and collagen-degrading enzymatic expression and activity
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
CD44 enhances invasion of basal-like breast cancer cells by upregulating serine protease and collagen-degrading enzymatic expression and activity ; volume:14 ; number:3 ; day:23 ; month:5 ; year:2012 ; pages:1-19 ; date:6.2012
Breast cancer research ; 14, Heft 3 (23.5.2012), 1-19, 6.2012
- Creator
-
Montgomery, Nicola
- Contributor
-
Hill, Ashleigh
McFarlane, Suzanne
Neisen, Jessica
O'Grady, Anthony
Conlon, Susie
Jirstrom, Karin
Kay, Elaine W.
Waugh, David JJ
SpringerLink (Online service)
- DOI
-
10.1186/bcr3199
- URN
-
urn:nbn:de:1111-2016032415045
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
22.08.20252025, 12:03 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Montgomery, Nicola
- Hill, Ashleigh
- McFarlane, Suzanne
- Neisen, Jessica
- O'Grady, Anthony
- Conlon, Susie
- Jirstrom, Karin
- Kay, Elaine W.
- Waugh, David JJ
- SpringerLink (Online service)
Other Objects (12)
The CD44+/CD24-phenotype is enriched in basal-like breast tumors
Murine osteoclasts secrete serine protease HtrA1 capable of degrading osteoprotegerin in the bone microenvironment
Extracellular matrix marker LAMC2 targets ZEB1 to promote TNBC malignancy via up-regulating CD44/STAT3 signaling pathway
Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells
Chondosarkom und CD44
Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype
Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44+ cancer stem cells to 5 azacytidine in hepatocellular carcinoma
Correction: Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44 + cancer stem cells to 5 azacytidine in hepatocellular carcinoma
FBXW7 E3 ubiquitin ligase: degrading, not degrading, or being degraded
Inside-out regulation of ectodomain cleavage: the state of a serine in the intracellular tail of CD44 regulates ectodomain accessibility by ADAMs
Die Bedeutung der Expression von CD44-h und seiner Isoformen CD44-v3, CD44-v6 und CD44-v9 sowie von E-Cadherin und PCNA für die klinische Progressionstendenz des Nierenzellkarzinoms
Die Bedeutung der Expression von CD44-h und seiner Isoformen CD44-v3, CD44-v6 und CD44-v9 sowie von E-Cadherin und PCNA für die klinische Progressionstendenz des Nierenzellkarzinoms
The CD44+/CD24-phenotype is enriched in basal-like breast tumors
Murine osteoclasts secrete serine protease HtrA1 capable of degrading osteoprotegerin in the bone microenvironment
Extracellular matrix marker LAMC2 targets ZEB1 to promote TNBC malignancy via up-regulating CD44/STAT3 signaling pathway
Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells
Chondosarkom und CD44
Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype
Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44+ cancer stem cells to 5 azacytidine in hepatocellular carcinoma
Correction: Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44 + cancer stem cells to 5 azacytidine in hepatocellular carcinoma
FBXW7 E3 ubiquitin ligase: degrading, not degrading, or being degraded
Inside-out regulation of ectodomain cleavage: the state of a serine in the intracellular tail of CD44 regulates ectodomain accessibility by ADAMs
Die Bedeutung der Expression von CD44-h und seiner Isoformen CD44-v3, CD44-v6 und CD44-v9 sowie von E-Cadherin und PCNA für die klinische Progressionstendenz des Nierenzellkarzinoms
Die Bedeutung der Expression von CD44-h und seiner Isoformen CD44-v3, CD44-v6 und CD44-v9 sowie von E-Cadherin und PCNA für die klinische Progressionstendenz des Nierenzellkarzinoms
The CD44+/CD24-phenotype is enriched in basal-like breast tumors
Murine osteoclasts secrete serine protease HtrA1 capable of degrading osteoprotegerin in the bone microenvironment
Extracellular matrix marker LAMC2 targets ZEB1 to promote TNBC malignancy via up-regulating CD44/STAT3 signaling pathway
Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells
Chondosarkom und CD44
Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype
Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44+ cancer stem cells to 5 azacytidine in hepatocellular carcinoma
Correction: Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44 + cancer stem cells to 5 azacytidine in hepatocellular carcinoma
FBXW7 E3 ubiquitin ligase: degrading, not degrading, or being degraded
Inside-out regulation of ectodomain cleavage: the state of a serine in the intracellular tail of CD44 regulates ectodomain accessibility by ADAMs
Die Bedeutung der Expression von CD44-h und seiner Isoformen CD44-v3, CD44-v6 und CD44-v9 sowie von E-Cadherin und PCNA für die klinische Progressionstendenz des Nierenzellkarzinoms